BMC Pulmonary Medicine (Jun 2019)

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions

  • Abdel-sadek Hamed Al-aarag,
  • Mohammad Hussein Kamel,
  • Eman Ramadan Abdelgawad,
  • Shaimaa Magdy Abo-Youssef,
  • Hany Hussein Moussa,
  • Marwa Elsayed Elnaggar,
  • Rasha Mohammad Hendy,
  • Koot Ahmad Diab

DOI
https://doi.org/10.1186/s12890-019-0874-y
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Tuberculous pleurisy and malignancy are two of the most common causes of pleural effusion. IL-33 is expressed in the epithelial lining and endothelial cells and is released after cell damage; it is proposed to have an essential role in sensing damage in various infectious and inflammatory diseases. This work aimed to determine the diagnostic role of IL-33 in pleural effusions. Methods One hundred seventeen patients with pleural effusions of different etiologies had a quantitative measurement of IL-33 in their pleural effusion and serum samples by ELISA technique. Results The concentrations of IL-33 (mean ± SD) in tuberculous pleural effusion (TPE) group (22.5 ± 0.90 ng/l) were significantly higher than that of malignant pleural effusion (MPE) group (14.6 ± 2.35 ng/l; P 0.05). The concentrations of IL-33 in the pleural effusions were significantly correlated to that of the serum concentrations in each group (TPE: r = 0.848, P = 1.4 with a sensitivity of 91.7% and specificity of 100% while for the determination of (MPE) was < 0.9 with a sensitivity of 83.3% and specificity of 96.4%. Conclusion IL-33 level may serve as a novel biomarker to differentiate pleural effusions, especially tuberculous from malignant effusions.

Keywords